Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A Cell-Based Assay Optimized for High-Content Cilia Imaging with Primary Rat Hippocampal Neurons

STAR Protocols(2020)10.1016/j.xpro.2020.100189Source: DataRank Database

A Cell-Based Assay Optimized for High-Content Cilia Imaging with Primary Rat Hippocampal Neurons is a research paper published in STAR Protocols (2020). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

Linked data & code

gen cellosaurus

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (14 grants)Impact (FWCI 0.32)OA: goldTopics (45)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Sara Vasquez,Mustafa Şahin ORCID,Alessia Di Nardo ORCID

Live enrichment

PubMed:33377083 PMC:PMC7757556 OpenAlex:https://openalex.org/W3110635330

National Institutes of Health

Grant: R01NS113591

Nancy Lurie Marks Family Foundation

Grant: U54HD090255

NINDS NIH HHS

Grant: U54 NS092090

National Institutes of Health

Grant: 5R01NS113591-04

Disrupted Ciliary Signaling in the Brain Pathology of Tuberous Sclerosis Complex

National Institutes of Health

Grant: 5U54HD090255-05

Boston Intellectual and Developmental Disabilities Research Center

Roche

Astellas Pharma US

Takeda Pharmaceutical Company

Biogen

Pfizer

LAM Therapeutics

Boston Children's Hospital

Novartis

Ipsen Biopharmaceuticals

FWCI

0.32

Citation Percentile

0.7%

Citation Trend

2021

2022

goldLicense: cc-by-nc-nd

journalhttps://www.sciencedirect.com/science/article/pii/S2666166720301763/pdf

publisherhttps://www.sciencedirect.com/science/article/pii/S2666166720301763/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2666166720301763?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2666166720301763?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.xpro.2020.100189

Fields of Study

Genetic and Kidney Cyst DiseasesCRISPR and Genetic EngineeringProtist diversity and phylogeny0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

AnimalsCells, CulturedCiliaHippocampusImage Processing, Computer-AssistedMicroscopyNeuronsRatsNeurogenesisPrimary Cell Culture

Keywords

CiliumHippocampal formationNeuroscienceGene silencingMotile ciliumLive cell imagingBiologyCellCell biologyPhenotypeHippocampusSmall hairpin RNAComputational biologyGeneRNAGeneticsMicroscopyCell-based AssaysNeuronsScience (General)NeurogenesisPrimary Cell CultureRatsQ1-390ProtocolImage Processing, Computer-AssistedAnimalsCiliaCells, Cultured

Sustainable Development Goals

SDG 0: Good health and well-being

A Cell-Based Assay Optimized for High-Content Cilia Imaging with Primary Rat Hippocampal Neurons

FAIR Checklist

Authors (3)

Funding (14 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)